Published in Tissue Antigens on March 01, 2003
Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol (2007) 1.55
High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer (2008) 1.20
Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients. Clin Dev Immunol (2010) 1.12
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression. BMC Cancer (2007) 1.04
Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer. J Proteome Res (2008) 1.04
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors. Immunogenetics (2010) 1.03
Colorectal cancer and immunity: what we know and perspectives. World J Gastroenterol (2014) 1.00
Clinical impact of HLA class I expression in rectal cancer. Cancer Immunol Immunother (2007) 0.92
Identification of E2F1 as an important transcription factor for the regulation of tapasin expression. J Biol Chem (2010) 0.90
Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes. Int J Cancer (2010) 0.86
Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. Immunogenetics (2004) 0.85
High-resolution analysis of HLA class I alterations in colorectal cancer. BMC Cancer (2006) 0.84
HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Semin Immunopathol (2011) 0.83
CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells. Int J Cancer (2012) 0.83
Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes. Cancer Immunol Immunother (2008) 0.81
Are BiTEs the "missing link" in cancer therapy? Oncoimmunology (2015) 0.81
Augmentation of effects of interferon-stimulated genes by reversal of epigenetic silencing: potential application to melanoma. Cytokine Growth Factor Rev (2007) 0.80
ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system. Oncotarget (2016) 0.78
Molecular mechanisms of uterine leiomyosarcomas: involvement of defect in LMP2 expression. Gene Regul Syst Bio (2008) 0.78
Loss of tapasin correlates with diminished CD8(+) T-cell immunity and prognosis in colorectal cancer. J Transl Med (2015) 0.78
AAV2-mediated in vivo immune gene therapy of solid tumours. Genet Vaccines Ther (2010) 0.77
Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer. Oncotarget (2016) 0.76
Emerging role of immunoproteasomes in pathophysiology. Immunol Cell Biol (2016) 0.75
KIR receptor-ligand incompatibility predicts killing of osteosarcoma cell lines by allogeneic NK cells. Pediatr Blood Cancer (2010) 0.75
Antigen processing and immune regulation in the response to tumours. Immunology (2016) 0.75
Restoration of expression of MHC class I molecule in Walker 256 tumor in growth dynamics in Brattleboro rats. Dokl Biochem Biophys (2010) 0.75
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today (1997) 2.89
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature (1999) 2.89
Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis (1990) 2.83
Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis (1991) 2.46
Diagnostic value of nonfluoroscopic percutaneous lung needle aspiration in patients with pneumonia. Chest (1990) 2.13
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment. Int J Cancer (2001) 2.07
Natural history of HLA expression during tumour development. Immunol Today (1993) 2.04
Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines. Nature (1976) 1.45
H-2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection. Nature (1976) 1.43
[Prolonged clinical pattern of brain death in patients under barbiturate sedation: usefulness of transcranial Doppler]. Neurologia (2002) 1.39
[Frequency of molecular alterations in heterozygous beta-thalassemia in southern Spain and their relation to the hematologic phenotype]. Sangre (Barc) (1994) 1.38
Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J Infect Dis (2001) 1.33
Maintenance of the normal rat alveolar macrophage cell population. The roles of monocyte influx and alveolar macrophage proliferation in situ. Am Rev Respir Dis (1987) 1.16
Air quality data from large cities. Sci Total Environ (2003) 1.08
The crystal structure of tetrameric methionine adenosyltransferase from rat liver reveals the methionine-binding site. J Mol Biol (2000) 1.08
Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. EMBO J (1995) 1.08
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer (1989) 1.08
The HLA crossroad in tumor immunology. Hum Immunol (2000) 1.06
HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res (1992) 1.05
HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clin Exp Metastasis (1990) 1.04
High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum Immunol (1996) 1.03
Prevalence and determinants of lead intoxication in Mexican children of low socioeconomic status. Environ Health Perspect (1996) 1.03
MHC antigens and malignancy. Nature (1986) 1.02
An arsenic(III)-oxidizing bacterial population: selection, characterization, and performance in reactors. J Appl Microbiol (2002) 1.02
Comparison of oral health among older people with and without dementia. Community Dent Health (2014) 1.01
Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx. Int J Cancer (1989) 1.01
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors. Int J Cancer (1999) 1.00
[Mammary carcinoma ine ectopic breast tissue. A case report]. Rev Med Chil (2001) 0.99
Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line. Cancer Immunol Immunother (1998) 0.99
Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol (1991) 0.99
Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther (1995) 0.99
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer (1990) 0.96
MHC expression on human tumors--its relevance for local tumor growth and metastasis. Semin Cancer Biol (1991) 0.96
Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells. Cancer Res (1997) 0.96
Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient. Cancer Immunol Immunother (2001) 0.96
Biological implications of HLA-DR expression in tumours. Scand J Immunol (1995) 0.96
Separation distress call in the human neonate in the absence of maternal body contact. Acta Paediatr (1995) 0.95
Methylated CpG points identified within MAGE-1 promoter are involved in gene repression. Int J Cancer (1996) 0.95
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens (1998) 0.95
Targeting HLA class I expression to increase tumor immunogenicity. Tissue Antigens (2012) 0.94
Alcohol consumption, low birth weight, and preterm delivery in the National Addiction Survey (Mexico). Int J Addict (1993) 0.93
Multiple mechanisms underlie HLA dysregulation in cervical cancer. Tissue Antigens (2000) 0.93
Expression of HLA G in human tumors is not a frequent event. Int J Cancer (1999) 0.93
Altered MHC class I antigens in tumors. Int J Clin Lab Res (1997) 0.92
MHC antigens on human tumors. Immunol Lett (1991) 0.91
Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy. Scand J Immunol (2009) 0.91
Tracking genetically engineered bacteria: monoclonal antibodies against surface determinants of the soil bacterium Pseudomonas putida 2440. J Bacteriol (1992) 0.91
Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line. Tissue Antigens (1996) 0.91
Molecular strategies to define HLA haplotype loss in microdissected tumor cells. Hum Immunol (2000) 0.90
Can the HLA phenotype be used as a prognostic factor in breast carcinomas? Int J Cancer Suppl (1991) 0.90
Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia. Int J Tuberc Lung Dis (2011) 0.90
Tumour immunology, vaccination and escape strategies. Eur J Immunogenet (2003) 0.90
Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI). Br J Pharmacol (2007) 0.90
Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line. Int J Clin Lab Res (1999) 0.90
Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness. Exp Clin Immunogenet (1987) 0.89
Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer (1990) 0.89
Primary cardiac paraganglioma. Case report and review of surgically treated cases. J Cardiovasc Surg (Torino) (1993) 0.89
Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines. Immunogenetics (2006) 0.88
ACTH and beta-endorphin in transcendental meditation. Physiol Behav (1998) 0.88
High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. Tissue Antigens (1998) 0.88
Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours. Tissue Antigens (2007) 0.88
HLA class I antigens in human tumors. Adv Cancer Res (1995) 0.88